
ABSTRACT Background Kidney injury during metabolic dysfunction‐associated steatotic liver disease (MASLD) progression remains incompletely characterized. Purpose To assess multiparametric MRI (mpMRI) for early detection and monitoring of MASLD‐associated kidney injury. Study Type Animal model. Animal Model Fifty male Sprague Dawley rats received high‐fat diet plus very low‐dose carbon tetrachloride (CCl 4 ) underwent mpMRI before sacrifice at 0, 2, 4, 8, or 12 weeks ( n = 10/time point). Ten MASLD and ten normal rats underwent serial MRI at each time point; ten CCl 4 ‐only rats served as nephrotoxicity controls. Twelve additional healthy rats underwent a scan‐rescan test. Field Strength/Sequence 3 T; turbo spin‐echo T2‐weighted imaging, variable flip angle (VFA) gradient‐echo T1 mapping, multi‐echo gradient‐echo blood oxygen level‐dependent imaging, pulsed arterial spin labeling, echo‐planar diffusion kurtosis imaging, and multi‐echo Dixon imaging. Assessment Two radiologists (5 and 13 years of experience) quantified T1, T2*, proton density fat fraction (PDFF), mean diffusivity, mean kurtosis (MK), and renal blood flow (RBF) in cortex, outer/inner stripes of outer medulla (OSOM/ISOM). Early injury was defined as a tubular injury score ≥ 2. Histopathology, immunohistochemistry, transcriptomics, and serum metabolomics were performed. Statistical Tests Repeated‐measures ANOVA; intraclass correlation coefficient (ICC); area under the receiver operating characteristic curve (AUC). p < 0.05 indicated significance. Results Scan‐rescan ICCs were 0.682–0.876. OSOM MK/PDFF significantly increased by Week 2 [MK (×10 −3 ): 0.532 ± 0.007 to 0.574 ± 0.004; PDFF (%): 2.489 ± 0.243 to 3.600 ± 0.347]; cortical RBF and OSOM T2* showed no significant changes at Week 2 ( p = 0.786, 1.000) but significantly decreased from Week 4. OSOM MK/PDFF had AUCs of 0.952 and 0.905 for early renal injury. Multi‐omics revealed inflammatory and lipid/bile acid alterations. Dodecanedioic/hippuric acids potentially linked MASLD severity to OSOM MK. Data Conclusion Renal mpMRI detected early kidney injury during MASLD progression. Evidence Level 2. Technical Efficacy Stage 2.
ABSTRACT Background Hepatic proton density fat fraction (PDFF) is often reported as a whole‐liver mean, without a population reference for individual fat distribution. Purpose To construct longitudinal, sex‐specific three‐dimensional PDFF atlases and assess regional fat loss, sex differences in heterogeneity, and metabolic associations. Study Type Prospective; secondary analysis of a randomized lifestyle intervention trial. Population A total of 127 adults with obesity imaged at baseline (, 73 female [F], 54 male [M]), after an 8‐week low‐caloric diet (, 49F/32M), and after 12‐month weight maintenance (, 40F/32M). Field Strength/Sequence 3T; six‐echo chemical shift‐encoded gradient‐echo. Assessment Sex‐ and visit‐specific atlases were built by deformable registration; z ‐maps quantified voxel‐wise deviation from the matched atlas. Six heterogeneity features (standard deviation [ σ x ], coefficient of variation [CV], entropy []; z ‐ skewness, z ‐kurtosis, volume fraction z > 2) were compared between sexes and correlated, cross‐sectionally and longitudinally, with hepatocellular, glycemic, adiposity markers and triglycerides, and longitudinally with steatosis remission (PDFF < 5%). Statistical Tests Welch t‐test; Spearman correlation ( ρ ); Benjamini–Hochberg correction within each test set. Significance at adjusted p < 0.05. Results Liver PDFF decreased significantly from to in males (13.6% ± 7.0% to 6.6% ± 2.5%) and females (9.1% ± 6.2% to 5.9% ± 3.3%) with regionally non‐uniform, sex‐specific patterns. At , σ x and H were significantly higher in males and CV, z ‐skewness and z ‐kurtosis in females; at , σ x (males) and z‐skewness and z‐kurtosis (females) remained significant; no feature differed at (adjusted p = [0.583–0.953]). Cross‐sectionally, features correlated with hepatocellular, glycemic and adiposity markers, more extensively in females. Longitudinally, significant correlations were almost limited to adiposity ( V 1 to V 3 : CV × visceral fat volume in females, ρ = −0.65; CV × visceral PDFF in males, ρ = −0.67); apart from × gamma‐glutamyl transferase in females, no feature tracked hepatocellular, glycemic or steatosis remission outcomes (adjusted p = [0.051–0.999], [0.092–0.999], and [0.073–0.887]). Data Conclusion Hepatic fat loss showed spatially heterogeneous and sex‐specific patterns. Heterogeneity reflected metabolic state cross‐sectionally but mainly adiposity change longitudinally. Evidence Level 2. Technical Efficacy Stage 1.
ABSTRACT Background White matter microstructure may be affected by cancer and its treatment, yet its association with subsequent cancer‐related cognitive impairment (CRCI) remains unclear. Purpose To investigate whether baseline white matter diffusion metrics are associated with the time to CRCI onset and longitudinal cognitive trajectories. Study Type Prospective longitudinal study. Population A total of 230 female patients (49.4 ± 8.6 years) with histopathologically confirmed breast cancer (50 Stage II, 180 Stage III) with planned neoadjuvant chemotherapy before surgery. Field Strength/Sequence A 3 T, multi‐shell SE ‐ EPI DWI . Assessment Diffusion MRI was performed before chemotherapy (baseline). Neuropsychological assessments were carried out at baseline, after the first cycle of chemotherapy, after completion of chemotherapy but before surgery, and at 2–4 years after surgery. Diffusion tensor metrics (mean, radial, and axial diffusivity [MD, RD, and AD]), diffusion kurtosis metrics (axial and radial kurtosis [AK and RK]), and neurite orientation dispersion and density imaging metrics (orientation dispersion index [ODI], neurite density index [NDI]) were extracted from 25 white matter tracts, capturing both mean values and peak width. Statistical Tests Cox regression and linear mixed‐effects models assessed associations with time to CRCI onset and cognitive trajectories, respectively. A p value < 0.05 was considered significant. Results Higher ODI (anterior limb of the internal capsule [ALIC]: HR = 1.28), lower AD (ALIC: HR = 0.72, external capsule [EC]: HR = 0.73, superior fronto‐occipital fasciculus [SFO]: HR = 0.70), and greater peak width of AK (ALIC: HR = 1.29, EC: HR = 1.24, genu of the corpus callosum [GCC]: HR = 1.32) were associated with earlier CRCI onset. Lower FA, RK, and MK ( β = 0.13 to 0.27 × 10 −3 ), higher MD, RD, ODI, and ISOVF ( β = −0.23 to −0.13 × 10 −3 ), and higher peak width metrics ( β = −0.34 to −0.13 × 10 −3 ) were associated with poorer longitudinal cognitive trajectories. Conclusions Pretreatment white matter microstructure may help identify patients at greater risk of CRCI and poorer cognitive trajectories. Level of Evidence 2. Technical Efficacy Stage 3.
ABSTRACT Background Morphometric measurements from structural brain MRI are sensitive to analysis pipelines and software versions. Purpose To evaluate inter‐pipeline agreement, reliability, and systematic measurement differences across automated morphometric software packages on identical structural MRI datasets. Study Type Systematic review (PROSPERO CRD420261456493). Population One hundred eleven studies comprising healthy and clinical cohorts across the lifespan. Field Strength/Sequence Predominantly 1.5 T and 3 T, with 7 T data also included. Assessment Automated and semi‐automated processing pipelines (predominantly FreeSurfer, FSL, and SPM/CAT) evaluated for brain volumes and cortical thickness. Statistical Tests Intraclass correlation coefficients (ICC), Pearson/Spearman correlation (r), Lin's concordance correlation coefficient (CCC), and Bland–Altman bias ( p < 0.05). Results Agreement varied across anatomical regions, software pairs, versions, and processing conditions. Strong associations coexisted with systematic measurement differences in several comparisons, but neither high association nor high agreement was consistent across global and regional outputs. Manual‐reference comparisons showed structure‐ and population‐dependent volume overestimation, with rankings differing by outcome metric. Cortical thickness, intracranial‐volume normalization, and normative percentiles showed additional method‐dependent differences. Software updates and preprocessing choices altered measurements and, in some studies, downstream findings. Computational repeatability, anatomical accuracy, and longitudinal‐change agreement represented distinct properties and did not consistently favor the same method. Data Conclusion High correlation or consistency does not ensure absolute agreement or interchangeability in MRI morphometry. Regional discrepancies vary across software pairs, versions, and processing conditions, limiting generalization of individual comparisons to other methods or populations. Evidence Level 1. Technical Efficacy Stage Stage 2.